From Corporate Authority to Independent Influence: D Forbes-Edelen on Why AI Is Redefining Value for Women in Transition

For many high-achieving women, leaving the corporate world is not just a career transition; it is an identity rupture.
PharmiWeb

Ono Pharma Announces New Drug Discovery Collaboration with Congruence Therapeutics in the Priority Areas of Neurology and Immunology

Beginning a new drug discovery collaboration using Congruence’s globally recognized Revenir™ platform for the creation of small molecule modulatorsExpanded collaboration into Ono’s other priority ...
PharmExec

Revealing the Structural Fingerprints of Disease: Q&A with Faraz Choudhury

Immuto CEO Faraz Choudhury spoke with Pharmaceutical Executive about his company’s work with focusing on Surface Protein Conformations (SPCs) for target discovery. According to him, traditional target ...
The Malaysian Reserve

Congruence and Ono Pharma Expand Multi-Target Research Partnership with the Addition of Two New Programs

Expanded collaboration continues to leverage Congruence's proprietary computational drug discovery engine, Revenir™ to deliver Development Candidates in ...